EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case–control study of overall survival

Lung Cancer ◽  
2013 ◽  
Vol 80 (3) ◽  
pp. 306-312 ◽  
Author(s):  
M. Faehling ◽  
R. Eckert ◽  
T. Kamp ◽  
S. Kuom ◽  
U. Griese ◽  
...  
Lung Cancer ◽  
1994 ◽  
Vol 11 (3-4) ◽  
pp. 191-199 ◽  
Author(s):  
Eduardo De Stéfani ◽  
Luis Fierro ◽  
María T. Larrinaga ◽  
Julio C. Balbi ◽  
Alvaro Ronco ◽  
...  

BMC Cancer ◽  
2016 ◽  
Vol 16 (1) ◽  
Author(s):  
Motoyasu Kato ◽  
Takehito Shukuya ◽  
Keita Mori ◽  
Ryota Kanemaru ◽  
Yuichiro Honma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document